CCL14 testing to guide clinical practice in patients with AKI: Results from an international expert panel-Reference-Cited by-同舟云学术

CCL14 testing to guide clinical practice in patients with AKI: Results from an international expert panel

Published:2024-08 Issue: Volume:82 Page:154816
ISSN:0883-9441
Container-title:Journal of Critical Care
language:en
Short-container-title:Journal of Critical Care

Author:

Kellum John A.,Bagshaw Sean M.,Demirjian Sevag,Forni Lui,Joannidis Michael,Kampf J. Patrick,Koyner Jay L.,Kwan Thomas,McPherson Paul,Ostermann Marlies,Prowle John,Ronco Claudio,de la Salle Julia,Schneider Antoine,Tolwani Ashita,Zarbock Alexander

Funder

bioMerieux

Publisher

Elsevier BV

Reference18 articles.

1. Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study;Hoste;Intensive Care Med,2020

2. External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury;Bagshaw;Crit Care,2021

3. Performance of a Standardized Clinical Assay for Urinary C-C Motif Chemokine Ligand 14 (CCL14) for Persistent Severe Acute Kidney Injury;Koyner;Kidney360,2022

4. Progressive AKIG: Comparison of C-C motif chemokine ligand 14 with other biomarkers for adverse kidney events after cardiac surgery;Massoth;J Thorac Cardiovasc Surg,2023

5. Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients;Meersch;Crit Care Med,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent acute kidney injury biomarkers: A systematic review and meta-analysis;Clinica Chimica Acta;2025-01

2. The incidence, risk factors, and prognosis of acute kidney injury in patients after cardiac surgery;Frontiers in Cardiovascular Medicine;2024-07-16